The 36-month beta value for MTNB is also noteworthy at 1.61. There are mixed opinions on the stock, with 3 analysts rating it as a
In the past week, MTNB stock has gone down by -3.42%, with a monthly decline of -4.14% and a quarterly surge of 18.54%. The volatility
Company’s 36-month beta value is 1.53.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as
Matinas Biopharma Holdings Inc (AMEX: MTNB)’s stock price has increased by 12.21 compared to its previous closing price of 0.27. However, the company has seen
Matinas Biopharma Holdings Inc (AMEX: MTNB)’s stock price has soared by 26.00 in relation to previous closing price of 0.24. Nevertheless, the company has seen
© 2024, Fueled by Smart TechOne
